Magnus Strandh
Magnus Strandh publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology, on topics such as Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research and Protein purification and stability.
- World rank
- #2,830,332 of 7,710,434 ranked researchers
- Rank in Denmark
- #21,010 of 43,819
- Works
- 22
- Citations
- 1.5k
- Citations per work
- 70.0
What does Magnus Strandh research?
Magnus Strandh's work is mostly in Biochemistry, Genetics and Molecular Biology (33%), Medicine (18%), Immunology and Microbiology (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1149.2%
- Everything else626.2%
- Health Sciences418.0%
- Medicine418.0%
- Physical Sciences16.6%
- Engineering16.6%
- 1Molecular Biology28% of their works
- 2Radiology, Nuclear Medicine and Imaging18% of their works
- 3Immunology10% of their works
- 4Microbiology7% of their works
- 5Biomedical Engineering7% of their works
- 6Molecular Medicine5% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- Glycosylation and Glycoproteins Research
- Protein purification and stability
- Antimicrobial Peptides and Activities
- Antibiotic Resistance in Bacteria
- Nanofabrication and Lithography Techniques
- Advanced biosensing and bioanalysis techniques
- Advanced Biosensing Techniques and Applications
Which keywords describe Magnus Strandh's research?
The keywords of their largest research topics: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Cancer, Glycans and Antimicrobial Peptides.
- Protein Microarrays
- DNA nanotechnology
- Nanolithography
- Antibiotic Resistance
- Host Defense
- Antimicrobial Peptides
- Cancer
- Antibody Engineering
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Fc Receptors
- Glycans
- Biopharmaceuticals
- Protein Aggregation
- Multidrug-Resistant Bacteria
- Soft Lithography
- High-Throughput Analysis
- Self-Assembly
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Glycosylation182 topics
- Monoclonal Antibodies152 topics
- Therapeutic Antibodies152 topics
- Antibody Engineering111 topic
- Fc Receptors111 topic
- Cancer71 topic
- Glycans71 topic
- Antimicrobial Peptides41 topic
- Biopharmaceuticals41 topic
- Host Defense41 topic
- Protein Aggregation41 topic
- Antibiotic Resistance31 topic
- Multidrug-Resistant Bacteria31 topic
- Nanolithography31 topic
- Soft Lithography31 topic
- DNA nanotechnology21 topic
- High-Throughput Analysis21 topic
- Protein Microarrays21 topic
- Self-Assembly21 topic
Where does Magnus Strandh work?
Magnus Strandh's main affiliation in the publication record is Symphogen (Denmark), Denmark.
How many publications and citations does Magnus Strandh have?
OpenAlex counts 22 works and 1,541 citations for Magnus Strandh, an h-index of 13, ranking #2,830,332 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Magnus Strandh. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.